# Silence Therapeutics Plc to Present at the Cowen 38th Annual Health Care Conference

- Link: https://www.directorstalkinterviews.com/silence-therapeutics-plc-present-cowen-38th-annual-health-care-conference/412746716
- Published: 2018-03-05T07:15:21+00:00
- Author: Giles Arbor

**Silence Therapeutics plc**, (LON:SLN) a leader in the discovery, delivery, and
development of novel RNA therapeutics for the treatment of serious diseases with
unmet medical need, announced today that Ali Mortazavi, Chief Executive Officer,
will present at the Cowen 38th Annual Health Care Conference on Tuesday, 13 March,
2018 at 10:30am EDT in Boston, MA.

The presentation will be webcast live and may be accessed by visiting Silence’s 
website at http://www.silence-therapeutics.com/investors/. A replay of the webcast
will be available for 14 business days.

Silence Therapeutics plc develops a new generation of medicines by harnessing the
body’s natural mechanism of RNA interference, or RNAi, within its cells. Our proprietary
technology can selectively inhibit any gene in the genome, specifically silencing
the production of disease-causing proteins. Using our enabling delivery systems,
we have achieved an additional level of specificity by delivering our therapeutic
RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries
and delivery systems are designed to improve the stability of our molecules and 
enhance effective delivery to target cells, providing a powerful modular technology
well suited to tackle life-threatening diseases.

Share on: